Alvotech And STADA Obtain Approval In Europe For Ustekinumab Biosimilar, UZPRUVO
On January 10, Alvotech announced that the European Commission issued a marketing authorization to its European commercialization partner, STADA, for UZPRUVO , a biosimilar referencing STELARA . The...